David Skarinsky

Back to Jobs

David Skarinsky is our Senior Vice President, Clinical and previously served as Vice President since joining Otonomy in January 2020. Mr. Skarinsky has over 30 years of experience leading multi-national clinical development programs from Phase I through Phase IV across a broad range of therapeutic areas, and providing support for regulatory filings and interactions with the FDA and foreign regulatory authorities. Prior to Otonomy, Mr. Skarinsky served as Vice President, Clinical Operations and Regulatory Affairs at Abide Therapeutics, a CNS drug developer acquired by H. Lundbeck A/S in 2019. He previously served as Vice President Clinical Operations at Nabriva Therapeutics and at Zavante Therapeutics (prior to its acquisition by Nabriva), where he led clinical operations from IND to NDA for the IV antibiotic ContepoTM. Mr. Skarinsky also held various multidisciplinary leadership positions during more than a decade of clinical research program management at Parexel International and Quintiles CNS Therapeutics, was responsible for clinical operations and project management at Hollis Eden Pharmaceuticals, and served in clinical program management roles at Rhone-Poulenc Rorer, Sanofi, and Medeva. He received his Bachelor’s degree in Neuroscience from Amherst College.

Apply Now